The role of the fluorodeoxyglucose (FDG) technique positron emission tomography (PET) is
well established in the management of patients with lung cancer. Increasingly, it is becoming …

The first British Thoracic Society (BTS) state-ment on mesothelioma was published in 2001
by a Working Party of the Standards of Care Committee of the BTS1 in response to a request …

Background Mesothelioma is a highly aggressive tumour for which there are no reliable
serum tumour markers. Identification of such a marker would be useful in diagnosis of …

BACKGROUND The role of fluorodeoxyglucose (FDG)-PET imaging for diagnosing
malignant pleural effusions is not well defined. The aim of this study was to summarize the …

PURPOSE: To evaluate the feasibility of technetium 99m (99mTc) ethylenedicysteine–
deoxyglucose (ECDG) imaging in tumor-bearing rodents. MATERIALS AND METHODS …

In the last hundred years, lung cancer has risen from a reportable disease to the most
common cause of death from cancer in both men and women in developed countries (1) …

Background Several studies have already addressed the potential role of an increased
fluorine 18 fluorodeoxyglucose (18 F FDG) uptake in identification of pleural malignancy. In …

The separation of benign reactive mesothelium (RM) from malignant mesothelial
proliferation can be a major challenge. A number of markers have been proposed, including …

Imaging plays an important role in the diagnosis and subsequent management of patients
with pleural disease. The presence of a pleural abnormality is usually suggested following a …

Purpose Response evaluation with conventional criteria based on computed tomography
(CT) is particularly challenging in malignant pleural mesothelioma (MPM) due to its diffuse …